Now showing items 1-1 of 1

    • Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study 

      Dumurgier, Julien; Schraen, Susanna; Gabelle, Audrey; Vercruysse, Olivier; Bombois, Stéphanie; Laplanche, Jean-Louis; Peoc’h, Katell; Sablonnière, Bernard; Kastanenka, Ksenia V; Delaby, Constance; Pasquier, Florence; Touchon, Jacques; Hugon, Jacques; Paquet, Claire; Lehmann, Sylvain (BioMed Central, 2015)
      Introduction: The cerebrospinal fluid (CSF) biomarkers amyloid-β (Aβ), tau and phosphorylated tau (p-tau181) are now used for the diagnosis of Alzheimer’s disease (AD). Aβ40 is the most abundant Aβ peptide isoform in the ...